Intelligence · Clinical Development
Pipeline search results
Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
A clinical trial of MK-6050 in healthy participants (MK-6050-002)
Merck Sharp and Dohme
Hidradenitis suppurativa
1 trial -
A clinical trial of MK-6916 in healthy participants (MK-6916-010)
Merck Sharp and Dohme
Acute and Chronic pain
1 trial -
A randomized for healthy male subjects
Lacuna Pharma Pty Ltd
healthy male subjects
1 trial -
A research study of a new medicine (NNC0650-0013) in healthy men
NovoThirteen
Weight management, Diabetes mellitus type 2; healthy subjects
1 trial -
A study in healthy men to test how BI 1569912 is processed in the body
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
A study in healthy men to test how BI 1584862 is processed in the body
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
A study in healthy people to compare two different Sifrol® tablets
Boehringer Ingelheim
Pharmacokinetic trial
1 trial -
A study in healthy people to compare two tablet formulations of pramipexole
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
A study in healthy people to test how vicadrostat affects the heart
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
A study to assess the safety of ARGX-121 in Healthy Adult Participants
argenx
Healthy volunteers
1 trial -
A study to compare two different aramchol formulations in healthy volunteers.
Galmed Pharmaceuticals
Nonalcoholic fatty liver disease, Nonalcoholic steatohepatitis, Primary sclerosing cholangitis
1 trial -
A study to evaluate how the body absorbs for Healthy Volunteers
Janssen-Cilag International N.V.
Healthy Volunteers
1 trial -
A study to find out how healthy people tolerate a new drug called S221237.
The George Institute
Parkinson disease (PD)
1 trial -
A trial to learn how baxdrostat affects the heartbeat in healthy participants
AstraZeneca AB
Treatment-resistant hypertension, Primary aldosteronism, Uncontrolled hypertension
1 trial -
A160_01AD2502
Lacuna Pharma Pty Ltd
Phase I study in healthy participants. Intended indication: atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis, eosinophilic esophagitis, prurigo nodularis, and chronic obstructive pulmonary disease
1 trial -
AB-SA01 (10^8 PFU per phage)
Armata Pharmaceuticals
Healthy Volunteers
1 trial -
AB680
Arcus Biosciences
Healthy Volunteers
2 trials -
ADX48621
Addex Therapeutics
Healthy
1 trial -
AG-181
Agios Netherlands B.V.
Healthy Volunteers
1 trial -
AG-236
Agios Netherlands B.V.
Healthy Participants
1 trial -
AG-348
Agios Netherlands B.V.
Healthy
1 trial -
AG-348
Agios Netherlands B.V.
Healthy Volunteer
2 trials -
AG-348
Agios Netherlands B.V.
Healthy Volunteers
1 trial -
AG-348 Sequence A
Agios Netherlands B.V.
Healthy Volunteers
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.